|
|
||||||||
|
Interact CardioVasc Thorac Surg 2006;5:299-300. doi:10.1510/icvts.2006.129502 © 2006 European Association of Cardio-Thoracic Surgery
Centrifugal blood pump use in routine cardiac surgerySt. Elisabeth Department of Heart and Lung Surgery, St. Olavs University Hospital and Faculty of Medicine, Norwegian University of Science and Technology NTNU, Hans Nissens gt. 3, 7018 Trondheim, Norway Received 24 January 2006; received in revised form 14 February 2006; accepted 16 February 2006
*Corresponding author. Tel: +47-73-867000; fax: +47-73-867029.
The literature on the use of centrifugal blood pumps in routine cardiac surgery provides conflicting evidence. Although two large studies revealed a reduction in neurological complications, many smaller studies found no difference in biochemical and clinical parameters. However, there is some evidence that centrifugal pumps perform significantly better in routine surgery compared to roller pumps.
Key Words: Centrifugal pump; Cardiopulmonary bypass; Extracorporeal circulation The superior blood handling properties of centrifugal blood pumps have led to their universal use in long-term extracorporeal circulation such as ECMO. The scientific evidence for their use in routine cardiac surgery, however, is still debatable. The best evidence paper titled Does the use of a centrifugal pump offer any additional benefit for patients having open heart surgery? by Asante-Siaw summarizes the literature on this topic [1]. The authors conclude that two large studies demonstrated a reduction of neurological events when a centrifugal pump was used, but that all remaining studies failed to show significant differences. Unfortunately a number of relevant publications were not included in the best evidence paper. A randomized trial published by our own group from the University of Regensburg was not included in the best evidence paper, although it included more patients than most of the randomized trials referenced [2]. One hundred and twenty patients were randomized to roller pump, centrifugal pump, or roller pump with aprotinin. The aim of the study was to investigate whether centrifugal pumps reduce blood loss during routine surgery to a similar extent as the addition of aprotinin. As shown in the table, we were unable to show such an effect. In addition, analysis of platelet function revealed similar results for all groups (Table 1).
Many of the published studies on centrifugal pumps, including our own, were not powered to show a clinical benefit with respect to mortality, organ failure, stroke, or length of stay in hospital. In addition, most trials included patients undergoing routine coronary surgery with relatively short periods of extracorporeal circulation. Nevertheless, a reduction in blood trauma when using centrifugal pumps was clearly shown in several in-vitro and in-vivo investigations. A randomized trial published by Jakob and co-workers found an advantage for the centrifugal pump with respect to several laboratory values, such as free hemoglobin, platelet count, and others [3]. Hoerr et al. showed an improved blood handling of centrifugal pumps compared to roller pumps [4]. Combining centrifugal pumps with other modifications of the extracorporeal circuit, aiming at reducing the invasiveness of cardiopulmonary bypass, have been shown to be advantageous, even in routine surgery [57].
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |